Piper Sandler Companies (PIPR) is not a good buy right now for a beginner investor focused on long-term investing, despite having $50,000-$100,000 available. The stock is technically weak and the current setup does not offer a clean long-term entry. I would not buy it today; hold off until the trend improves.
PIPR is in a clear bearish technical trend. The MACD histogram is negative and expanding, showing downside momentum is still worsening. RSI_6 at 12.714 indicates the stock is heavily oversold, which can lead to a short-term bounce, but oversold alone is not enough to justify a buy. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend across both short and intermediate timeframes. Price at 71.09 is sitting just above S1 support at 71.72 and near S2 at 68.728, so the stock is trading close to a support zone, but the trend remains weak. For a beginner long-term investor who does not want to wait for ideal timing, this is still not an attractive entry.

["Goldman Sachs raised its price target to $97 from $88 and kept a Buy rating.", "The firm noted modestly improved expectations for M&A and debt capital markets activity.", "Insider selling is not a positive catalyst by itself, but there is no major negative congress trading data.", "The stock is technically oversold, which can support a short-term rebound."]
["Price action remains bearish with SMA_200 > SMA_20 > SMA_5 and negative expanding MACD.", "Insiders are selling, and the selling amount increased 285.82% over the last month.", "Hedge funds are neutral with no significant accumulation trend.", "No AI Stock Picker signal today.", "No SwingMax buy signal recently.", "No recent congress trading data available.", "Financial snapshot data was unavailable, limiting confirmation of fundamental momentum."]
Latest quarter financials were not available because the financial snapshot returned an error, so there is no reliable quarter-by-quarter growth data to assess here. The only fundamental-related read-through is from Goldman Sachs' note that estimates were modestly adjusted higher due to slightly better M&A and debt capital markets activity, which is supportive but not enough to confirm strong operating momentum.
Analyst sentiment is positive overall. Goldman Sachs analyst James Yaro raised the price target to $97 from $88 and maintained a Buy rating on 2026-04-14. The broader read is constructive, with improved expectations tied to investment banking activity. Wall Street pros appear bullish on medium-term upside, but the current stock trend and insider selling weaken the case for an immediate purchase.